AKT1 and osteoporosis: Although Wnt/Akt/MAPK/AMPK pathways exert important functions in bone homeostasis and bone related diseases, and new therapies are constantly emerging, the current therapeutic environment for osteoporosis is limited, therefore new side-effect free drugs and therapeutic targets are required (Gera et al., 2022; Kobayakawa et al., 2022).